학술논문

Exploring the Mechanism of Echinatin against Cervical Cancer Based on Network Pharmacology.
Document Type
Article
Source
Journal of Clinical Pharmacy & Therapeutics. 4/8/2024, Vol. 2024, p1-14. 14p.
Subject
*THERAPEUTIC use of antineoplastic agents
*CHINESE medicine
*COMPUTER-assisted molecular modeling
*CANCER invasiveness
*FLAVONOIDS
*HERBAL medicine
*ANTINEOPLASTIC agents
*PHARMACEUTICAL chemistry
*APOPTOSIS
*CELLULAR aging
*CELL proliferation
*CELL cycle
*CELLULAR signal transduction
*CELL motility
*GLYCYRRHIZA
*MOLECULAR structure
*GENE expression profiling
*WESTERN immunoblotting
*WOMEN'S health
*THERAPEUTICS
*PHARMACODYNAMICS
CERVIX uteri tumors
Language
ISSN
0269-4727
Abstract
Cervical cancer significantly impacts women's health due to its high mortality rate and increasing prevalence among younger individuals, thereby posing a severe threat. Echinatin is the primary active component of licorice in traditional Chinese medicine. However, studies on its use in cervical cancer treatment are limited. In our study, 198 targets of Echinatin were identified by some databases. Among these, 40 core targets related to cervical cancer were selected. Enrichment analyses revealed that Echinatin operated through genes associated with cell cycle, apoptosis, senescence, and various cancer-related signaling pathways. Differential expression of intersecting targets was verified in the GEO database, and molecular docking also indicated a strong binding capacity between active compounds and identified targets. Moreover, the results of western blot provided further evidence at the protein level. Echinatin hindered the proliferation, migration, and invasion of HeLa and SiHa cells while increasing their apoptosis. This study predicted the potential targets and beneficial effects of Echinatin in cervical cancer treatment, which provides a new avenue for further research into the molecular mechanisms underlying the role of Echinatin in cervical cancer treatment. [ABSTRACT FROM AUTHOR]